The FDA has approved Osphena (ospemifene), from Shionogi, for the treatment of moderate to severe Dyspareunia (painful intercourse), a symptom...
Duchesnay announced that it has submitted a supplemental New Drug Application to the FDA seeking a new indication for Osphena...
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation...